Design of the Trial to Assess Chelation Therapy (TACT)
- 31 January 2012
- journal article
- research article
- Published by Elsevier BV in American Heart Journal
- Vol. 163 (1), 7-12
- https://doi.org/10.1016/j.ahj.2011.10.002
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Development and evaluation of the Seattle Angina questionnaire: A new functional status measure for coronary artery diseaseJournal of the American College of Cardiology, 1995
- Chelation therapy for intermittent claudication. A double-blind, randomized, controlled trial.Circulation, 1994
- EDTA treatment of intermittent claudication — a doubleblind, placebo‐controlled studyJournal of Internal Medicine, 1992
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990
- A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index)The American Journal of Cardiology, 1989
- EDTA chelation therapy in chronic degenerative diseaseMedical Hypotheses, 1988
- Discrete Sequential Boundaries for Clinical TrialsBiometrika, 1983
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- NEPHROTOXIC HAZARD FROM UNCONTROLLED EDATHAMIL CALCIUM-DISODIUM THERAPYJournal of the American Medical Association, 1956
- Use of Ethylene Diamine Tetra Acetic Acid in Hypercalcemic Patients.Experimental Biology and Medicine, 1953